The Latest Breaking News on Pharma

The ‘huge disadvantage’ women behind femtech phenomenon face

Despite growing demand for female health solutions, businesses are coming up against entrenched prejudice

The Guardian - UK · Oct 8, 2024

Activist Starboard Takes $1 Billion Stake In Pfizer, Seeks Former Execs' Support: Reports

Starboard has reached out to former Pfizer CEO Ian Read and ex-finance chief Frank D'Amelio, and both have expressed interest in supporting the activist investor's turnaround efforts, reports said.

International Business Times · Oct 7, 2024

CDC Warns Of Dangerous Counterfeit Drugs From Online Pharmacies, Highlighting Overdose Risk

The warning follows last week's U.S. Department of Justice (DOJ) indictment of illegal online pharmacies selling counterfeit prescription pills laced with fentanyl and methamphetamine to tens of thousands of people in the U.S., leading to at least nine deaths.

Medical Daily · Oct 4, 2024

3 Biotech Stocks Wall Street Predicts Will Skyrocket

Biotech companies could gain the financial flexibility to accelerate their innovations with the Fed’s recent rate cut. To capitalize on this opportunity, consider investing in fundamentally sound biotech stocks Biogen (BIIB), Royalty Pharma (RPRX), and BioMarin Pharmaceutical (BMRN), that are poised to skyrocket. Learn more.

StockNews.com · Sep 25, 2024

Nasal spray flu vaccine approved for home use: Here’s what to know

Vaccine provides an alternative to flu shots administered with needles

The Independent UK · Sep 24, 2024

Minister vows 'assertive' approach on vape crackdown

While a ban on vape sales is starting to have an effect, Health Minister Mark Butler says further action is needed on stores that are illegally selling them.

AAP · Sep 22, 2024

Gavi secures 500,000 doses of mpox vaccine for Africa amid outbreak

The Gavi vaccine alliance has reached an agreement with Danish pharmaceutical company Bavarian Nordic to obtain 500,000 doses of mpox vaccine for African countries dealing with an outbreak of the virus.

Radio France Internationale · Sep 18, 2024

DEA shutting down two offices in China even as agency struggles to stem flow of fentanyl chemicals

The U.S. Drug Enforcement Administration is closing two of its offices in China, a move that comes even as the agency struggles to disrupt the flow of precursor chemicals from the country that have fueled a fentanyl epidemic

The Independent UK · Sep 16, 2024

Gilead’s biannual HIV shot reduced risk of infections by 96 percent, company says

The drugmaker said its injections were 89 percent more effective than its own Truvada

The Independent UK · Sep 13, 2024

Moderna Stock Plunges as Vaccine Maker Slashes R&D Budget: What to Know

Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.

Kiplinger · Sep 12, 2024